A study of T1 relaxation time as a measure of liver fibrosis and the influence of confounding histological factors

NMR in Biomedicine

Volumn 28, Issue 6, 2015, Pages 706-714

  Hoad, Caroline L ^a,b   Palaniyappan, Naaventhan ^b   Kaye, Philip ^b   Chernova, Yulia ^b   James, Martin W ^b   Costigan, Carolyn ^a   Austin, Andrew ^c   Marciani, Luca ^b   Gowland, Penny A ^a   Guha, Indra N ^b   Francis, Susan T ^a   Aithal, Guruprasad P ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^c ROYAL DERBY HOSPITAL   (United Kingdom)

Author keywords

Fibrosis; Hepatobiliary; Inflammation; Iron; Other applications; Relaxometry

Indexed keywords

BIOPSY; DECISION TREES; IRON; PATHOLOGY; PERSONNEL TRAINING;

CHRONIC LIVER DISEASE; CONFIDENCE INTERVAL; DECISION TREE MODELING; FIBROSIS; HEPATOBILIARY; INFLAMMATION; RECEIVER OPERATOR CURVES; RELAXOMETRY;

RELAXATION TIME;

IRON;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FATTY LIVER; HISTOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MIDDLE AGED; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELAXATION TIME; VALIDATION PROCESS; YOUNG ADULT; ARTIFACT; COMPLICATION; COMPUTER ASSISTED DIAGNOSIS; FEMALE; LIVER; MALE; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADULT; ARTIFACTS; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IRON; LIVER; LIVER CIRRHOSIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84929273786     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.3299     Document Type: Article

References (32)

1. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD. Liver biopsy. Hepatology 2009; 49(3): 1017-1044.
2. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38(6): 1449-1457.
3. Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, Grimaldi A, Capron F, Poynard T. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005; 128(7): 1898-1906.
4. Seeff LB, Everson GT, Morgan TR, Curto TM, Lee WM, Ghany MG, Shiffman ML, Fontana RJ, Di Bisceglie AM, Bonkovsky HL, Dienstag JL. Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clin. Gastroenterol. Hepatol. 2010; 8(10): 877-883.
5. Guha IN, Parkes J, Roderick PR, Harris S, Rosenberg WM. Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease. Gut 2006; 55(11): 1650-1660.
6. Guha IN, Rosenberg WM. Noninvasive assessment of liver fibrosis: serum markers, imaging, and other modalities. Clin. Liver Dis. 2008; 12(4): 883-900, x.
7. Horslev-Petersen K, Bentsen KD, Halberg P, Junker P, Kivirikko KI, Majamaa K, Risteli L, Risteli J, Lorenzen I. Connective tissue metabolites in serum as markers of disease activity in patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 1988; 6(2): 129-134.
8. Castera L, Foucher J, Bernard PH, Carvalho F, Allaix D, Merrouche W, Couzigou P, de Ledinghen V. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13369 examinations. Hepatology 2010; 51(3): 828-835.
9. Arena U, Vizzutti F, Corti G, Ambu S, Stasi C, Bresci S, Moscarella S, Boddi V, Petrarca A, Laffi G, Marra F, Pinzani M. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 2008; 47(2): 380-384.
10. Coco B, Oliveri F, Maina AM, Ciccorossi P, Sacco R, Colombatto P, Bonino F, Brunetto MR. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J. Viral Hepatol. 2007; 14(5): 360-369.
11. Sagir A, Erhardt A, Schmitt M, Haussinger D. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology 2008; 47(2): 592-595.
12. Millonig G, Reimann FM, Friedrich S, Fonouni H, Mehrabi A, Buchler MW, Seitz HK, Mueller S. Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology 2008; 48(5): 1718-1723.
13. Asbach P, Klatt D, Schlosser B, Biermer M, Muche M, Rieger A, Loddenkemper C, Somasundaram R, Berg T, Hamm B, Braun J, Sack I. Viscoelasticity-based staging of hepatic fibrosis with multifrequency MR elastography. Radiology 2010; 257(1): 80-86.
14. Yin M, Talwalkar JA, Glaser KJ, Manduca A, Grimm RC, Rossman PJ, Fidler JL, Ehman RL. Assessment of hepatic fibrosis with magnetic resonance elastography. Clin. Gastroenterol. Hepatol. 2007; 5(10): 1207-1213 e2.
15. Wang Y, Ganger DR, Levitsky J, Sternick LA, McCarthy RJ, Chen ZE, Fasanati CW, Bolster B, Shah S, Zuehlsdorff S, Omary RA, Ehman RL, Miller FH. Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging. Am. J. Roentgenol. 2011; 196(3): 553-561.
16. Banerjee R, Pavlides M, Tunnicliffe EM, Piechnik SK, Sarania N, Philips R, Collier JD, Booth JC, Schneider JE, Mun Wang L, Delaney DW, Fleming KA, Robson MD, Barnes E, Neubauer S. Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. J. Hepatol. 2014; 60(1): 69-77.
17. Kuhn JP, Hernando D, Munoz del Rio A, Evert M, Kannengiesser S, Volzke H, Mensel B, Puls R, Hosten N, Reeder SB. Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging results. Radiology 2012; 265(1): 133-142.
18. 2*mapping for the determination of hepatic iron overload. Eur. Radiol. 2012; 22(11): 2478-2486.
19. 1 relaxation time in patients with liver cirrhosis. Eur. Radiol. 2012; 22(6): 1224-1232.
20. 1 in patients with liver cirrhosis: an in vivo MRI study. Magn. Reson. Imaging 1990; 8(5): 599-604.
21. Cox EF, Hoad CL, Francis SF. Quantification of renal T1 using a modified respiratory triggered inversion recovery TrueFISP scheme [Abstract]. In 19th Annual Meeting of the ISMRM, Montreal, 2011; 825.
22. Ye FQ, Mattay VS, Jezzard P, Frank JA, Weinberger DR, McLaughlin AC. Correction for vascular artifacts in cerebral blood flow values measured by using arterial spin tagging techniques. Magn. Reson. Med. 1997; 37(2): 226-235.
23. de Bazelaire CM, Duhamel GD, Rofsky NM, Alsop DC. MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0T: preliminary results. Radiology 2004; 230(3): 652-659.
24. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat. Methods Med. Res. 1999; 8: 135-160.
25. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41(6): 1313-1321.
26. Lichtinghagen R, Pietsch D, Bantel H, Manns MP, Brand K, Bahr MJ. The enhanced liver fibrosis (ELF) score: normal values, influence factors and proposed cut-off values. J. Hepatol. 2013; 59(2): 236-242.
27. St Pierre TG, Clark PR, Chua-Anusorn W. Single spin-echo proton transverse relaxometry of iron-loaded liver. NMR Biomed. 2004; 17(7): 446-458.
28. Wood JC, Enriquez C, Ghugre N, Tyzka JM, Carson S, Nelson MD, Coates TD. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 2005; 106(4): 1460-1465.
29. Zhao F, Wang YX, Yuan J, Deng M, Wong HL, Chu ES, Go MY, Teng GJ, Ahuja AT, Yu J. MR T1ρ as an imaging biomarker for monitoring liver injury progression and regression: an experimental study in rats with carbon tetrachloride intoxication. Eur. Radiol. 2012; 22(8): 1709-1716.
30. Stanisz GJ, Webb S, Munro CA, Pun T, Midha R. MR properties of excised neural tissue following experimentally induced inflammation. Magn. Reson. Med. 2004; 51(3): 473-479.
31. Tanwar S, Trembling PM, Guha IN, Parkes J, Kaye P, Burt AD, Ryder SD, Aithal GP, Day CP, Rosenberg WM. Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease. Hepatology 2013; 57(1): 103-111.
32. Noren B, Forsgren MF, Dahlqvist Leinhard O, Dahlstrom N, Kihlberg J, Romu T, Kechagias S, Almer S, Smedby O, Lundberg P. Separation of advanced from mild hepatic fibrosis by quantification of the hepatobiliary uptake of Gd-EOB-DTPA. Eur. Radiol. 2013; 23(1): 174-181.